Clinical Trial Update: Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating the use of sintilimab with a modified FLOT regimen for metastatic gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Modified FLOT regimen
• Sintilimab (sintilimab)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer, Chemotherapy Effect | Phase 2 | Status: UNKNOWN